Cargando…
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians
The Gleason grading system for prostate cancer (PCa) was developed in the 1960s by DF Gleason. Due to changes in PCa detection and treatment, the application of the Gleason grading system has changed considerably in pathology routine practice. Two consensus conferences were held in 2005 and in 2014...
Autores principales: | Gasparrini, Silvia, Cimadamore, Alessia, Scarpelli, Marina, Massari, Francesco, Doria, Andrea, Mazzucchelli, Roberta, Cheng, Liang, Lopez-Beltran, Antonio, Montironi, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337944/ https://www.ncbi.nlm.nih.gov/pubmed/28782737 http://dx.doi.org/10.4103/aja.aja_24_17 |
Ejemplares similares
-
Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021) -
Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression
por: Cimadamore, Alessia, et al.
Publicado: (2017) -
Lesson from the COVID-19 pandemic: pathologists need to build their confidence on working in a digital microscopy environment
por: Montironi, Rodolfo, et al.
Publicado: (2021) -
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation
por: Cimadamore, Alessia, et al.
Publicado: (2021) -
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)